SCHEMBL7897472

SCHEMBL7897472

C=CCOC(N)[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)C[C@@H]1O

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TK1 P04183 6/20 0.55
POLB P06746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL95903 0.82 DUT (0.45)
SCHEMBL316663 0.82 TK1 (0.65) TK1POLB
SCHEMBL6923318 0.82 TK1 (0.56) TK1
SCHEMBL6832176 0.82 TK1 (0.56) TK1
SCHEMBL6827431 0.82 TK1 (0.56) TK1
SCHEMBL25752530 0.81 TK1 (0.70) TK1POLB
SCHEMBL25364264 0.80 TK1 (0.60) TK1
SCHEMBL25364258 0.80 TK1 (0.60) TK1
SCHEMBL31298661 0.80 TK1 (0.60) TK1
SCHEMBL6379327 0.80 TK1 (0.67) TK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6191266-B1 MODIFIED TO COMPRISE SUBSTITUTIONS AT POSITIONS C1', C3', C4' OR C5' OF THE SUGAR MOIETY OF THE NUCLEOSIDE, INCLUDING AN OPTIONAL 3' PHOSPHOROAMIDITE GROUP; USE IN MAKING NUCLEASE RESISTANT OLIGONUCLEOTIDES FOR ANTISENSE THERAPY ICN PHARMACEUTICALS, INC. 2001-02-20 US disclosed